ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction
Year: 1992
Type: article
Study design: Clinical Trial
Source: The Lancet
Authors: D Hunt, George Varigos, F Dienstl, Peter Lechleitner, G DeBacker, Marcel Kornitzer, J. Cairns, Alexander G. G. Turpie, Per Fritz-Hansen, Knud Skagen, R Kala, J Heikkilä, Jean Boissel, Alain Leizorovicz, Rolf Schröder, K Kothe, N. B. Karatzas, J� Horgan, Declan OʼCallaghan, G Tognoni, M. Franzosi, Aldo P. Maggioni, Adam F. Cohen, R Köster, Hillary D. White, Stephen MacMahon, J. Kjekshus, Åsmund Reikvam, L Ceremuźyński, Ernesto Paolasso, Rienzi Díaz‐Navarro, Vicent Valentín, Lars Wilhelmsen, L Lundkvist, T Moccetti, Roberto Malacrida, Michele Genoni, R Collins, Peter Sleight, Richard Peto, Sarah Parish, Richard E. Doll, Paul Armitage, S.A. Cederholm-Williams, Michael Conway, Peter Dove, Marcus Flather, J. Jeffrey Marshall, Linda Youngman, Desmond Julian, D. A. Chamberlain, C P Warlow, Peter Sandercock, Keith A.A. Fox, C H Hennekens, Samuel Z. Goldhaber, GERALD C. TIMMIS, Salim Yusuf, Petra Meier
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: British Heart Foundation
OpenAlex ID: W4251417417